These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 2642754)

  • 1. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
    Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
    Glueck CJ
    Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
    Ojala JP; Helve E; Karjalainen K; Tarkkanen A; Tikkanen MJ
    Atherosclerosis; 1990 May; 82(1-2):85-95. PubMed ID: 2360923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
    Kuo PT; Wilson AC; Kostis JB; Moreyra AE
    Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probucol with colestipol in the treatment of hypercholesterolemia.
    Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M
    Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled studies of the efficacy and safety of combined probucol-colestipol therapy.
    Dujovne CA; Krehbiel P; Chernoff SB
    Am J Cardiol; 1986 Jun; 57(16):36H-42H. PubMed ID: 3524176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination drug therapy for familial combined hyperlipidemia.
    East C; Bilheimer DW; Grundy SM
    Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
    Helve E; Tikkanen MJ
    Atherosclerosis; 1988 Aug; 72(2-3):189-97. PubMed ID: 3063268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G; Witztum J; Basich P
    Artery; 1982; 10(2):99-104. PubMed ID: 7092583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR; Bacon S
    Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H
    Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB; Bell C; Olson L
    Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.
    Valeri A; Gelfand J; Blum C; Appel GB
    Am J Kidney Dis; 1986 Dec; 8(6):388-96. PubMed ID: 3544820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein fractions and receptors: a role for probucol?
    Bilheimer DW
    Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
    Illingworth DR
    Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
    Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4124-8. PubMed ID: 6575399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
    Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of probucol on xanthomata regression in familial hypercholesterolemia.
    Yamamoto A; Matsuzawa Y; Yokoyama S; Funahashi T; Yamamura T; Kishino B
    Am J Cardiol; 1986 Jun; 57(16):29H-35H. PubMed ID: 3728307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.
    Weisweiler P; Merk W; Jacob B; Schwandt P
    Eur J Clin Pharmacol; 1986; 30(2):191-4. PubMed ID: 3709644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lecithin: cholesterol acyltransferase activity in familial hypercholesterolemia treated with simvastatin and simvastatin plus low-dose colestipol.
    Desager JP; Horsmans Y; Harvengt C
    J Clin Pharmacol; 1991 Jun; 31(6):537-42. PubMed ID: 1880219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.